FIELD: medicine.
SUBSTANCE: new crystal form II N-benzoilstaurosporin is described, as well as pharmaceutical composition containing it, inhibiting protein kinase C; ways of obtaining crystalline form of compounds, and the use of crystal form of II N-benzoilstaurosporin for treatment neoplastic diseases. Crystalline form of II N-benzoilstaurosporin is a stable form of N-benzoilstaurosporin with low hygroscopicity.
EFFECT: suitability in pharmaceutical compositions.
21 cl, 2 tbl, 4 dwg, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF STAUROSPORIN PURIFICATION AND METHOD OF OBTAINING N-BENZOYLSTAUROSPORIN | 2005 |
|
RU2467012C2 |
| CRYSTALLINE FORM III AND IV OF N-BENZOYLSTAUROSPORINE | 2010 |
|
RU2598378C2 |
| POLYMORPHIC FORMS OF MACROCYCLIC HCV INHIBITOR | 2008 |
|
RU2533830C2 |
| NOVEL CRYSTALLINE FORM OF PERINDOPRIL | 2005 |
|
RU2387641C2 |
| COMPOUND, CERTAIN NOVEL FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS BASED THEREON AND METHODS OF PRODUCTION AND USE | 2010 |
|
RU2507203C1 |
| SYNTHESYS OF HYDRATED 4-AMINO-5-CHLORO-2-METHOXY-N-(1-AZA-BICYCLO[3,3,1]NON-4-YL)BENZAMIDE HYDROCLORIDE POLYMORPH | 2004 |
|
RU2337102C2 |
| NEW SALTS OF ANTICONVULSANT COMPOUNDS | 2003 |
|
RU2330041C2 |
| SYNTHESIS OF N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE, AS WELL AS TARTRATE AND CRYSTALLINE FORMS THEREOF | 2005 |
|
RU2417986C2 |
| SALTS AND POLYMORPHIC MODIFICATIONS OF THE INHIBITOR VEGF-R | 2006 |
|
RU2369607C1 |
| METHOD OF PRODUCING N-[5-(3,5-DIFTORBENZIL)-1H-INDAZOLE-3-YL]-4-(4-METHYLPIPERAZINE-1-YL)-2-(TETRAHYDROPYRAN-4-YLAMINO)BENZAMIDE | 2013 |
|
RU2602071C2 |
